PLSE
Pulse Biosciences, Inc.
Medical Instruments & Supplies · Healthcare · United States
52.24
close · 2026-10-30
value
6
cheaper than peers6
quality
13
stronger fundamentals13
ranked against
Medical Instruments & Supplies
value
quality
33 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, 3 years ago | -1.3% | 35 |
| earnings yield, latest year | -2.1% | 35 |
| earnings yield, 1 year ago | -1.8% | 35 |
| earnings yield, 3 years ago | -3.2% | 33 |
| cash flow yield, 2 years ago | -0.9% | 26 |
| earnings yield, 2 years ago | -1.6% | 26 |
| cash flow yield, latest year | -1.5% | 17 |
| cash flow yield, 1 year ago | -1.0% | 17 |
| price to book | 37.18× | 5 |
| price to sales | 3144.21× | 2 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 6.8% | 78 |
| return on equity | -78.5% | 5 |
| operating margin | -5823.0% | 5 |
3 of 4 measures available
Facts
| market cap | $4B |
| free cash flow | -$34.3M |
| employees | 116 |
| first trade | 2016-05-18 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -1.08 | -0.92 | -0.85 | -1.69 |
| free cash flow | -$54.5M | -$36.5M | -$33.2M | -$47.4M |
| net income | -$72.8M | -$53.6M | -$42.2M | -$58.5M |
| revenue | $350,000 | $0 | $0 | $700,000 |